64 results
Page 2 of 4
8-K
EX-99.1
1ea6o 8vowjc
28 Feb 22
Arvinas Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:56pm
8-K
EX-99.1
t1mdhw
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
EX-1.1
ii2ijrd78t75tqi s5l8
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
7ikkcgfmph9gn 9475
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-10.1
q9igrs
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-10.2
ydtlm
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-99.1
0o4kjwf
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
rt6pe1iuheoexq
1 Mar 21
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:03pm
8-K
EX-1.1
5336z1ya0401
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
ilivvtj
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
eh0 7dd8u3vzrmg
14 Dec 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
yln1z6xs
5 Nov 20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:31am